The main mechanism of action of agonist CD40 antibodies is the activation of DCs and other antigen-presenting cells50, thus targeting a cellular compartment that is essential not only for priming and activation of T cells, but also to support the functionality of T cells in the tumor microenvironment63. This evidence concerns the gene CD40 and neoplasm.